Terbinafine manufacturer?

See the DrugPatentWatch profile for Terbinafine

Who first brought terbinafine to market?
Pfizer introduced terbinafine (brand name Lamisil®) in the early 1990s as the first oral antifungal targeting dermatophyte infections. The company’s formulation was the foundation for later generic versions.

Which companies now offer terbinafine generics?
After the original patents expired, several manufacturers entered the market, including Sandoz, Teva, Mylan, and Sun Pharmaceutical. These companies produce the same active ingredient under different brand names or as plain generics.

Are there differences in product quality between brands?
All FDA‑approved terbinafine products meet the same standards for purity, strength, and bioavailability. Minor variations in excipients may exist, but these do not affect therapeutic efficacy.

What about pricing?
Generic terbinafine is significantly cheaper than the original branded version. Prices vary by region and pharmacy, but typical costs are between $10–$30 for a 14‑day supply, compared with $70–$100 for the branded drug.

Does patent law affect new entrants?
Pfizer’s patents on the formulation and specific dosage forms expired in the late 2000s. Generic manufacturers can now produce the drug, provided they meet regulatory requirements. No major patent disputes have surfaced since then.

Can I expect side‑effect differences between brands?
Side‑effect profiles are identical across manufacturers. Common adverse events include gastrointestinal upset, headache, and mild liver enzyme changes. Serious events are rare and not brand‑specific.

Are there alternative antifungal options?
Other oral antifungals, such as itraconazole and fluconazole, exist but are typically used for different infection types or when terbinafine is contraindicated. Their mechanisms, dosing schedules, and cost structures differ.

Where can I find a reputable supplier?
Check the drug’s FDA approval status or the European Medicines Agency’s database before purchasing. Pharmacies that maintain a verified generic list are generally reliable sources.